Actemra: Uses, Side Effects & Warnings
Generic name: tocilizumab Drug class: Interleukin inhibitors Dosage form: intravenous (infusion) injection, subcutaneous injection Availability: Prescription only Pregnancy & Lactation: Risk data available Brand names: Actemra actpen , Tocilizumab , Tofidence What is Actemra? Actemra (tocilizumab) is a FDA approved biological medicine that is given by intravenous infusion or injection under the skin to treat specific patients with COVID-19, rheumatoid arthritis, giant cell arteritis, scleroderma, polyarticular or systemic juvenile idiopathic arthritis, and severe cytokine release syndrome. Actrema was FDA approved to treat COVID-19 on December 21, 2022, for specific adult patients. Pediatric patients (aged 2 years to 18 years) with COVID-19 still have access to Actrema under emergency use ...